Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 May-Aug;13(2):110-118.
doi: 10.11138/ccmbm/2016.13.2.110. Epub 2016 Oct 5.

Hereditary Multiple Exostoses: a review of clinical appearance and metabolic pattern

Affiliations
Review

Hereditary Multiple Exostoses: a review of clinical appearance and metabolic pattern

Giovanni Beltrami et al. Clin Cases Miner Bone Metab. 2016 May-Aug.

Abstract

Hereditary multiple exostoses (HME) is an inherited genetic condition characterized by the presence of multiple exostoses (osteochondromas). MHE is a relatively rare autosomal dominant disorder, mainly caused by loss of function mutations in two genes: exostosin-1 (EXT1) and exostosin-2 (EXT2). These genes are linked to heparan sulfate (HS) synthesis, but the specific molecular mechanism leading to the disruption of the cartilage structure and the consequent exostoses formation is still not resolved. The aim of this paper is to encounter the main aspects of HME reviewing the literature, in order to improve clinical features and evolution, and the metabolic-pathogenetic mechanisms underlying. Although MHE may be asymptomatic, a wide spectrum of clinical manifestations is found in paediatric patients with this disorder. Pain is experienced by the majority of patients, even restricted motion of the joint is often encountered. Sometimes exostoses can interfere with normal development of the growth plate, giving rise to limb deformities, low stature and scoliosis. Other many neurovascular and associated disorders can lead to surgery. The most feared complication is the malignant transformation of an existing osteochondroma into a secondary peripheral chondrosarcoma, during adulthood. The therapeutic approach to HME is substantially surgical, whereas the medical one is still at an experimental level. In conclusion, HME is a complex disease where the paediatrician, the geneticist and the orthopaedic surgeon play an interchangeable role in diagnosis, research and therapy. We are waiting for new studies able to explain better the role of HS in signal transduction, because it plays a role in other bone and cartilage diseases (in particular malignant degeneration) as well as in skeletal embryology.

Keywords: EXT1; EXT2; HS synthesis; Hereditary Multiple Exostoses; osteochondromas.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Organization of the embryonic growth plate (69).
Figure 2
Figure 2
Model of ostochondroma formation (69).
Figure 3
Figure 3
Clinical evolution of a coxa valga in a young HME (32).
Figure 4
Figure 4
A case of a 35-year woman with a vascular claudication, due to a chronic obstruction of the popliteal artery.
Figure 5
Figure 5
A case of a dedifferentiated chondrosarcoma.

Similar articles

Cited by

References

    1. Campanacci M. Bone and soft tissue tumors. Bologna: Springer-Verlag Wien GmbH; 1990.
    1. Schmale GA, Conrad EU, III, Raskind WH. The natural history of hereditary multiple exostoses. J Bone Joint Surg Am. 1994;76A:986e92. - PubMed
    1. Ryckx A, Somers JF, Allaert L. Hereditary multiple exostosis. Acta Orthop Belg. 2013;79(6):597–607. - PubMed
    1. Shapiro F, Simon S, Glimcher HJ. Hereditary multiple exostoses. Anthropometric, roentgenographic, and clinical aspects. J Bone Joint Surg Am. 1979;61A:815e24. - PubMed
    1. Wicklund CL, Pauli RM, Johnston D, Hecht JT. Natural history study of hereditary multiple exostoses. Am J Med Genet. 1995;55:43e6. - PubMed

LinkOut - more resources